Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 17 - Issue 1 - January 2020

Feature

Endovascular Technique
How to Prepare For, and Treat, Potential Complications in the Outpatient Endovascular Center
05/03/2020
Raymond Dattilo, MD, discusses how working in an office-based lab prompts certain considerations that do not exist in a hospital setting.
Raymond Dattilo, MD, discusses how working in an office-based lab prompts certain considerations that do not exist in a hospital setting.
Raymond Dattilo, MD, discusses...
05/03/2020
Vascular Disease Management
A Case of Bull Gore Injury Causing Pseudoaneurysm of the Lumbar Artery and Arteriovenous Fistula With Inferior Vena Cava
Case Report
A Case of Bull Gore Injury Causing Pseudoaneurysm of the Lumbar Artery and Arteriovenous Fistula With Inferior Vena Cava
01/03/2020
A re-bleeding retroperitoneal hematoma following surgical exploration for penetrating trauma is a challenging clinical scenario.
A re-bleeding retroperitoneal hematoma following surgical exploration for penetrating trauma is a challenging clinical scenario.
A re-bleeding retroperitoneal...
01/03/2020
Vascular Disease Management

Insights

Commentary Regarding Katsanos et al's Meta-Analysis: The Lessons Learned Should Impose Prudence and Caution
Commentary
Commentary Regarding Katsanos et al's Meta-Analysis: The Lessons Learned Should Impose Prudence and Caution
01/14/2020
Francesco Liistro, MD, comments on the meta-analysis presented by Katsanos et al.
Francesco Liistro, MD, comments on the meta-analysis presented by Katsanos et al.
Francesco Liistro, MD, comments...
01/14/2020
Vascular Disease Management
Interview
The ASPREE Trial and the Epidemic of CLI in Elderly Patients
01/03/2020
Mahmood Razavi, MD, reviewed the ASPREE trial and its implications for patients with CLI at the 2019 AMPutation Prevention Symposium in Chicago, Illinois. What were the goals of the ASPREE trial? 
Mahmood Razavi, MD, reviewed the ASPREE trial and its implications for patients with CLI at the 2019 AMPutation Prevention Symposium in Chicago, Illinois. What were the goals of the ASPREE trial? 
Mahmood Razavi, MD, reviewed the...
01/03/2020
Vascular Disease Management
Interview
Hypertension and Hyperlipidemia Treatment in CLI Patients
01/03/2020
Lawrence Garcia, MD, discusses hypertensive therapy for CLI patients, as well as the importance of managing CLI patients from a global perspective.
Lawrence Garcia, MD, discusses hypertensive therapy for CLI patients, as well as the importance of managing CLI patients from a global perspective.
Lawrence Garcia, MD, discusses...
01/03/2020
Vascular Disease Management
Commentary
The Paclitaxel-Coated Conundrum: A Commentary Article
01/14/2020
Michael Patel, MD, and Robert Beasley, MD discuss drug-eluting stents and drug-coated balloons.
Michael Patel, MD, and Robert Beasley, MD discuss drug-eluting stents and drug-coated balloons.
Michael Patel, MD, and Robert...
01/14/2020
Vascular Disease Management

Column

The Trend Toward Performing Procedures in Outpatient Centers Will Continue
Editor's Corner
The Trend Toward Performing Procedures in Outpatient Centers Will Continue
01/03/2020
Craig Walker, MD, comments on a “must read” article for anyone who may be contemplating performing interventions in an outpatient endovascular center.
Craig Walker, MD, comments on a “must read” article for anyone who may be contemplating performing interventions in an outpatient endovascular center.
Craig Walker, MD, comments on a...
01/03/2020
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

January 2020 Volume 17 Issue 1

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement